Skip to main content

Steve Jobs (the movie)

NeXT logo.svg

I recently saw the latest biopic about Apple co-founder and re-fashioner of industries Steve Jobs.

It was a fine movie. The Rolling Stone reviewer calls it brilliant. But it hasn't been a commercial success. 

Why not? I don't know, but I'll make the simple observation that it is the antithesis of an action film. It isn't even a very visual film, it could almost have been done on the radio. Everything depended on the dialog. Still, that dialogue was very well-written and acted by a world-class cast.

It is written as a three act play, and each act is a product launch. Various backstage dramas each time precede the moment when Jobs walks on stage to unveil a new product to the world. We also get some quick flash back scenes to events the characters are talking about, and some very brief news anchor narration in inter-act transitions.

The essentials of the familiar story are conveyed through this structure. Job and Woz co-founded Apple. As it outgrew them, Woz became associated with the Apple II and Job with other products, more innovative but less remunerative. Also, as the company grew, the founders had to bring in a professional CEO as 'adult supervision.' That was John Scully, a veteran of Pepsico. Scully and the board eventually rebelled against Jobs' high-handedness and fired him. Later, in deeper troubles, the board fired Scully and brought back Jobs. All that, as I say, will be familiar to most of the audience interested enough to go to this movie.

What was surprising to me was that the movie made NO MENTION OF PIXAR AT ALL. The "Elba" period in Jobs' life is represented in this movie, and within the 3-act structure, by the launch of the Cube, the key product of NeXT, a company Jobs later sold to Apple as part of his own triumphant return to its executive suite. If you followed the above link to the Rolling Stone rave you may have noticed that the critic there mentioned Pixar near the top, as one of the reasons Jobs was worth making a movie around.

But ... more dramatically relevant, Pixar was at least as important a part of Jobs' work during the Elba period as was NeXT. And Toy Story was a success whereas the NeXT Cube was largely a flop. I've also mentioned the Jobs/Pixar connection in this blog before, and I have to admit that I understand the problem. Jobs' work with Pixar wouldn't have fit within the three-act structure. A movie's grand opening doesn't look at all like a computer's product launch. Still, to consign it to the memory hole seems a bit much.


  1. Do you drink Pepsi or Coca-Cola?
    ANSWER THE POLL and you could get a prepaid VISA gift card!


Post a Comment

Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.

We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…